Oral triptans vs. other classes of acute migraine medication [1]

Cephalalgia

Volumn 26, Issue 5, 2006, Pages 628-

  Tfelt Hansen, P ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SUMATRIPTAN; TOLFENAMIC ACID; TRIPTAN DERIVATIVE;

ACUTE DISEASE; CLINICAL PRACTICE; CLINICAL STUDY; CLINICAL TRIAL; DRUG EFFICACY; DRUG FORMULATION; HUMAN; LETTER; MIGRAINE; SAMPLE SIZE; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ANALGESICS; HUMANS; MIGRAINE DISORDERS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; TRYPTAMINES;

EID: 33646003255     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2006.01074.x     Document Type: Letter

References (4)

1. Lipton RB Bigal ME Goadsby PJ Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review Cephalalgia 2004 24 321 32
2. Myllylä VV Hanvanka H Herrala L Kangasneimi P Rautakorpi I Turkka J et al. Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: comparable effect in a double-blind, randomized, controlled, parallel group study Headache 1998 38 201 7
3. GEA A/S (Data on file).
4. Ferrari MD Goadsby PJ Roon KI Lipton RB Triptans (Serotonin, 5-HT 1b/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials Cephalalalgia 2002 22 633 58